Clinical Trial Update: Safety and Feasibility of Metformin for Sepsis Induced AKI [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the safety and feasibility of metformin for sepsis-associated acute kidney injury, with enrollment currently by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis
• Septic Shock

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Hernando Gomez | Conditions: Sepsis, Septic Shock | Phase 2 | Status: ENROLLING_BY_INVITATION